On July 3, 2023, Santhera Pharmaceuticals Holding AG (SIX: SANN) completed a 10:1 reverse split of its shares,

which had been approved by the shareholders on June 27, 2023, with the listing and first day of trading of the post-split shares on the SIX Swiss Exchange.

The transaction was enabled by a rule change that made reverse splits much easier for Swiss public companies after January 1, 2023.

The Homburger team was led by Daniel Häusermann (Corporate / M&A, Capital Markets) and included Stefan Oesterhelt (Tax), Jasmin Künzle and Martin Cattaneo (both Corporate / M&A, Capital Markets) as well as Eduard De Zordi and Philipp Klein (both Capital Markets).

3rd July 2023